1,596 hedge funds and large institutions have $95.7B invested in Amgen in 2017 Q1 according to their latest regulatory filings, with 151 funds opening new positions, 679 increasing their positions, 576 reducing their positions, and 71 closing their positions.

New
Increased
Maintained
Reduced
Closed

more first-time investments, than exits

New positions opened: | Existing positions closed:

more funds holding in top 10

Funds holding in top 10:

more repeat investments, than reductions

Existing positions increased: | Existing positions reduced:

more capital invested

Capital invested by funds: $ → $

4% more funds holding

Funds holding: 1,5371,596 (+59)

1.05% more ownership

Funds ownership: 78.07%79.12% (+1%)

33% less call options, than puts

Call options by funds: $1.14B | Put options by funds: $1.7B

Holders
1,596
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
79
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$1.14B
Puts
$1.7B
Net Calls
Net Calls Change

Top Buyers

1 +$7.63B
2 +$2.24B
3 +$584M
4
Barclays
Barclays
United Kingdom
+$245M
5
Goldman Sachs
Goldman Sachs
New York
+$161M

Top Sellers

1 -$1.34B
2 -$387M
3 -$149M
4
Primecap Management
Primecap Management
California
-$147M
5
O
OrbiMed
New York
-$147M
Name Holding Trade Value Shares
Change
Change in
Stake
1351
$320K
1352
$319K
1353
$319K
1354
$319K
1355
$319K
1356
$318K
1357
$317K
1358
$317K
1359
$315K
1360
$313K
1361
$313K
1362
$312K
1363
$310K
1364
$308K
1365
$305K
1366
$305K
1367
$305K
1368
$304K
1369
$303K
1370
$302K
1371
$298K
1372
$297K
1373
$295K
1374
$295K
1375
$293K